• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2025 Aug 4;25(1):977.
doi: 10.1186/s12879-025-11357-9. Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring

Ilham Morani[SUP] 1 2 [/SUP], Haneen Shibli[SUP] 3 [/SUP], David Karasik[SUP] 3 [/SUP], Michael Edelstein[SUP] 3 [/SUP]



Affiliations
Abstract

Objectives: Acute respiratory tract infections (ARI), including COVID-19, are a significant global health challenge with pandemic potential. Understanding factors influencing ARI susceptibility and severity in different populations is crucial for pandemic preparedness and mitigation. We investigated epidemiological risk factors for COVID-19 susceptibility and severity in the Israeli population.
Methods: Participants who took a COVID-19 PCR test between July 2021 and August 2022 completed an online survey including demographics, comorbidities, infection and vaccination status. We identified factors associated with SARS-CoV-2 infection and disease severity using logistic regression and compared our results with the global literature.
Results: We included 2128 participants. Of these 823 participants were tested positive for SARS-CoV-2. Individuals without COPD and BMI > 30 had higher infection odds (aOR = 6.21, 95% CI:1.42-27.25 and aOR = 1.54, 95% CI:1.02-2.32; respectively). High school-level education was associated with increased susceptibility and severity compared to higher education (aOR = 1.55, 95% CI:1.1-2.18 and aOR = 2.80, 95% CI 1.62-4.86; respectively). Hospitalization was associated with older age (p < 0.001). Vaccination with 3 doses significantly reduced infection and hospitalization risk compared to unvaccinated (aOR = 0.024, 95% CI:0.016-0.04 and aOR = 0.37, 95% CI: 0.17-0.81; respectively, p < 0.05). Compared to Arab participants, Jewish ones were less likely to be infected (aOR = 1.48, 95% CI:1.02-2.15, p < 0.05).
Conclusions: Identified risk factors are consistent with meta-analyses of studies from other countries. Similar to other countries, minority groups were found to be at higher risk, therefore risk models predicting ARI susceptibility and severity have to take this into account.

Keywords: Acute respiratory tract infection; Coronavirus (COVID-19); Epidemiological risk factors; Israel.

 
Back
Top Bottom